Clinical characteristics | b (SE) | Crude HR (95% CI) | Wald statistic | p value |
---|---|---|---|---|
Histologic type | ||||
WHO type I | 0.00 | 1.00 | – | – |
WHO type I | 0.37 (0.25) | 1.45 (0.892, 2.37) | 2.25 | 0.134 |
WHO type I | 0.05 (0.59) | 1.06 (0.33, 3.38) | 0.59 | 0.928 |
T-classification | ||||
T1 | 0.00 | 1.00 | – | – |
T2 | 0.15 (0.54) | 1.16 (0.40, 3.36) | 0.08 | 0.780 |
T3 | 0.45 (0.49) | 1.56 (0.60, 4.05) | 0.85 | 0.357 |
T4 | 0.40 (0.44) | 1.49 (0.63, 3.52) | 0.81 | 0.368 |
N-classification | ||||
N0 | 0.00 | 1.00 | – | – |
N1 | − 0.03 (0.47) | 0.97 (0.39, 2.42) | 0.00 | 0.952 |
N2 | 0.25 (0.43) | 1,28 (0.55, 2.95) | 0.33 | 0.567 |
N3 | 0.77 (0.40) | 2.16 (0.99, 4.73) | 3.69 | 0.055 |
Metastases | ||||
M0 | 0.00 | 1.00 | – | – |
M1 | 1.11 (0.44) | 3.02 (1.29, 7.09) | 6.45 | 0.011 |
Staging | ||||
I–II | 0.00 | 1.00 | – | – |
III | 0.45 | 1.81 (0.75, 4.38) | 1.72 | 0.190 |
IV | 0.44 | 3.41 (1.44, 8.08) | 7.79 | 0.005 |